Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Welcure Drugs & Pharmaceuticals's Dividend Yield % or its related term are showing as below:
BOM:524661's Dividend Yield % is not ranked *
in the Medical Distribution industry.
Industry Median: 2.87 * Ranked among companies with meaningful Dividend Yield % only.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:524661 vs MCK, COR, CAH: Dividend Yield % Comparison
For the Medical Distribution subindustry, Welcure Drugs & Pharmaceuticals's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Welcure Drugs & Pharmaceuticals Dividend Yield % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Welcure Drugs & Pharmaceuticals's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Welcure Drugs & Pharmaceuticals's Dividend Yield % falls into.
Welcure Drugs & Pharmaceuticals (BOM:524661) has a Dividend Yield % of 0.00% as of Jul. 28, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Welcure Drugs & Pharmaceuticals and its competitors. According to the industry distribution chart, Welcure Drugs & Pharmaceuticals ranks #999999 out of 69 companies in the Medical Distribution industry.
Is Welcure Drugs & Pharmaceuticals' Dividend Yield % too high?
Welcure Drugs & Pharmaceuticals' current Dividend Yield % is 0.00%. Based on the distribution chart, Welcure Drugs & Pharmaceuticals ranks #999999 out of 69 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Welcure Drugs & Pharmaceuticals has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Welcure Drugs & Pharmaceuticals' Dividend Yield % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Welcure Drugs & Pharmaceuticals ranks #999999 out of 69 companies for Dividend Yield %. This places Welcure Drugs & Pharmaceuticals in the lower half of its industry. The industry median Dividend Yield % is 2.87. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Medical Distribution company?
The median Dividend Yield % among Medical Distribution companies is 2.87, based on 69 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Welcure Drugs & Pharmaceuticals and its competitors. For the Medical Distribution industry, the median Dividend Yield % is 2.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Welcure Drugs & Pharmaceuticals's current Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Welcure Drugs & Pharmaceuticals stock overvalued right now?
Welcure Drugs & Pharmaceuticals (BOM:524661) has a current Dividend Yield % of 0.00%. The current Dividend Yield % is 0.00%. Welcure Drugs & Pharmaceuticals' overall GF Score™ is 19/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Welcure Drugs & Pharmaceuticals (BOM:524661), the current Dividend Yield % is 0.00% as of Jul. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Welcure Drugs & Pharmaceuticals Business Description
Welcure Drugs & Pharmaceuticals Ltd is a pharmaceutical company. The company operates exclusively in a single business segment: the trading of medical products. The company's revenue is entirely derived from this segment, encompassing a range of activities from sourcing pharmaceutical products to facilitating their distribution in domestic and international markets.
19GF Score
Get the complete analysis for BOM:524661
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524661 has been successfully added to your 
